L. Rice

Clinical Biochemistry · 2000–2019

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 8 researchers here, as inferred from the citation graph.

Subfields

Whom L. Rice trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Frederick M. Cohan

Who trusts L. Rice overall

  1. Sirijan Santajit
  2. A. Howard
  3. N. Indrawattana
  4. H. Boucher
  5. M. O’Donoghue
  6. Sarah M. Drawz
  7. A. Feeney
  8. Mainul Haque
  9. Mansura S. Mulani
  10. Roy D. Sleator

Papers from L. Rice's perspective

Ordered by how strongly the researchers L. Rice trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Bacteria Fight Back (Science)
  2. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (Clinical Infectious Diseases)
  3. What are bacterial species? (Annual Review of Microbiology)
  4. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
  5. Genomic insights that advance the species definition for prokaryotes. (Proceedings of the National Academy of Sciences of the United States of America)
  6. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. (Journal of Infectious Diseases)
  7. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
  8. Linezolid resistance in a clinical isolate of Staphylococcus aureus. (The Lancet)
  9. Global Challenge of Multidrug-Resistant Acinetobacter baumannii (Antimicrobial Agents and Chemotherapy)
  10. Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli (Antimicrobial Agents and Chemotherapy)

Their papers